China Life Insurance Company Limited (2628) Free Cash Flow 2021–2025

Name: China Life Insurance Company Limited (2628) free cash flow history 2021-2025
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-08-10

China Life Insurance Company Limited annual free cash flow for fiscal 2025 was CNY 456.9 billion, an increase of 21.9% from CNY 374.8 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

2628 Annual Free Cash Flow

Free Cash Flow (annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	CNY 456.9B	CNY 374.8B	CNY 380.2B	CNY 348.9B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2628 Quarterly Free Cash Flow

Free Cash Flow (quarterly)	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Free Cash Flow	CNY 174.8B	CNY 58.7B	CNY 108.2B	CNY 190.5B	CNY 30.7B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Free Cash Flow at Comparable Companies

8795 Free Cash Flow — T&D Holdings, Inc.
7181 Free Cash Flow — Japan Post Insurance Co., Ltd.
8729 Free Cash Flow — SONY FINANCIAL GROUP INC
2318 Free Cash Flow — Ping An Insurance (Group) Company of China, Ltd.
1299 Free Cash Flow — AIA Group Limited
0945 Free Cash Flow — Manulife Financial Corporation

More 2628 metrics: Revenue · Net Income · EPS

All 2628 financial statements → Interactive 2628 charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.